Naltrexone-induced dysphoria
in former opioid addicts
by
Crowley TJ, Wagner JE, Zerbe G, Macdonald M.
Am J Psychiatry. 1985 Sep;142(9):1081-4.

ABSTRACT

Naltrexone treatment, used to prevent relapse among former opioid addicts, is reported to have an extraordinary rate of noncompliance. Since activation of opioid receptors produces a sense of well-being, naltrexone's blockade of these receptors might produce dysphoria, which could contribute to noncompliance among addicts under treatment. To test this hypothesis, the authors administered naltrexone to four men who had been free of opioids for 9 to 44 months using a 6-week, placebo-controlled crossover design. One subject dropped out with abstinence-like symptoms, and two others reported mild but significantly greater dysphoria during naltrexone administration. The results suggest that naltrexone may induce mild dysphoria long after addicts stop using opioids.

Pain
'Vivitrex'
Morphine
Tramadol
Naloxone
Nociceptin
Oxycodone
6beta-naltrexol
Naltrexone: suicide risk?
Ultra-low-dose naltrexone
Naltrexone plus buprenorphine
Naltrexone (Trexan) : structure
Naltrexone (Trexan) and sexual addicts

Refs
HOME
HedWeb
BLTC Research
Designer Drugs
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?